A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress

Siegel Mph, 2023, Cancer statistics, 2023, CA Cancer J Clin, 73, 17, 10.3322/caac.21763 Schmidt, 1997, Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas, Nat. Genet., 16, 68, 10.1038/ng0597-68 Gherardi, 2012, Targeting MET in cancer: rationale and progress, Nat. Rev. Cancer, 12, 89, 10.1038/nrc3205 Saraon, 2021, Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches, Oncogene, 40, 4079, 10.1038/s41388-021-01841-2 Sekino, 2022, Molecular mechanisms of resistance to tyrosine kinase inhibitor in clear cell renal cell carcinoma, Int. J. Urol., 29, 1419, 10.1111/iju.15042 Marona, 2019, C-met as a key factor responsible for sustaining undifferentiated phenotype and therapy resistance in renal carcinomas, Cells, 8, 10.3390/cells8030272 Chakraborty, 2019, Activation of c-Met in cancer cells mediates growth-promoting signals against oxidative stress through Nrf2-HO-1, Oncogenesis, 8, 1, 10.1038/s41389-018-0116-9 Balan, 2017, Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth, Sci. Rep., 7, 1, 10.1038/s41598-017-05455-1 Choi, 2012, vol. 15, 9 Nitti, 2017, HO-1 induction in cancer progression: a matter of cell adaptation, Antioxidants, 6, 29, 10.3390/antiox6020029 Na, 2014, Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1, Free Radic. Biol. Med., 67, 353, 10.1016/j.freeradbiomed.2013.10.819 Gañán-Gómez, 2013, Oncogenic functions of the transcription factor Nrf2, Free Radic. Biol. Med., 65, 750, 10.1016/j.freeradbiomed.2013.06.041 Moscat, 2016, p62 in cancer: signaling adaptor beyond autophagy, Cell, 167, 606, 10.1016/j.cell.2016.09.030 Katsuragi, 2016, Regulation of the keap1–nrf2 pathway by p62/SQSTM1, Curr Opin Toxicol, 1, 54, 10.1016/j.cotox.2016.09.005 Adinolfi, 2023, The KEAP1-NRF2 pathway: targets for therapy and role in cancer, Redox Biol., 63, 10.1016/j.redox.2023.102726 Chen, 2010, Autophagy and tumorigenesis, FEBS Lett., 584, 1427, 10.1016/j.febslet.2009.12.034 Bata, 2021, Cell survival and cell death at the intersection of autophagy and apoptosis: implications for current and future cancer therapeutics, ACS Pharmacol. Transl. Sci., 4, 1728, 10.1021/acsptsci.1c00130 Patel, 2020, The roles of autophagy and senescence in the tumor cell response to radiation, Radiat. Res., 194, 103, 10.1667/RADE-20-00009 Jiang, 2023, Drug-induced oxidative stress in cancer treatments: angel or devil?, Redox Biol., 63, 10.1016/j.redox.2023.102754 Perillo, 2020, ROS in cancer therapy: the bright side of the moon, Exp. Mol. Med., 52, 192, 10.1038/s12276-020-0384-2 Wu, 2021, The non-canonical effects of heme oxygenase-1, a classical fighter against oxidative stress, Redox Biol., 47, 10.1016/j.redox.2021.102170 Nakamura, 2019, Suppression of autophagic activity by Rubicon is a signature of aging, Nat. Commun., 10, 1, 10.1038/s41467-019-08729-6 Wong, 2018, Rubicon: LC3-associated phagocytosis and beyond, FEBS J., 285, 1379, 10.1111/febs.14354 Magné, 2022, LC3-associated endocytosis and the functions of Rubicon and ATG16L1, Sci. Adv., 8, 10.1126/sciadv.abo5600 Marukawa, 2023, Rubicon can predict prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant chemoradiotherapy, Int. J. Clin. Oncol., 28, 576, 10.1007/s10147-023-02306-0 Sabarwal, 2022, A Combination therapy using an mTOR inhibitor and Honokiol effectively induces autophagy through the modulation of AXL and Rubicon in renal cancer cells and restricts renal tumor growth following organ transplantation, Carcinogenesis, 43, 360, 10.1093/carcin/bgab126 Singh, 2017, U.S. Food and Drug Administration approval: cabozantinib for the treatment of advanced renal cell carcinoma, Clin. Cancer Res., 23, 330, 10.1158/1078-0432.CCR-16-1073 Park, 2021, Immune cell mediated cabozantinib resistance for patients with renal cell carcinoma, Integr. Biol., 13, 259, 10.1093/intbio/zyab018 Koinis, 2020, Resistance to MET/VEGFR2 inhibition by cabozantinib is mediated by YAP/TBX5-Dependent induction of FGFR1 in castration-resistant prostate cancer, Cancers, 12, 244, 10.3390/cancers12010244 Lin, 2020, Natural compounds as potential adjuvants to cancer therapy: preclinical evidence, Br. J. Pharmacol., 177, 1409, 10.1111/bph.14816 Majolo, 2019, Medicinal plants and bioactive natural compounds for cancer treatment: important advances for drug discovery, Phytochem. Lett., 31, 196, 10.1016/j.phytol.2019.04.003 Rawat, 2021, Ursolic acid disturbs ROS homeostasis and regulates survival-associated gene expression to induce apoptosis in intestinal cancer cells, Toxicol. Res., 10, 369, 10.1093/toxres/tfab025 Lewinska, 2017, Phytochemical-induced nucleolar stress results in the inhibition of breast cancer cell proliferation, Redox Biol., 12, 469, 10.1016/j.redox.2017.03.014 Rauf, 2018, Honokiol: an anticancer lignan, Biomed. Pharmacother., 107, 555, 10.1016/j.biopha.2018.08.054 Hamedani, 2020, Novel Honokiol-eluting PLGA-based scaffold effectively restricts the growth of renal cancer cells, PLoS One, 15, 10.1371/journal.pone.0243837 Sabarwal, 2020, A novel combination treatment with Honokiol and rapamycin effectively restricts c-met-induced growth of renal cancer cells, and also inhibits the expression of tumor cell PD-L1 involved in immune escape, Cancers, 12, 1782, 10.3390/cancers12071782 Sabarwal, 2022, A novel 4′-brominated derivative of fisetin induces cell cycle arrest and apoptosis and inhibits EGFR/ERK1/2/STAT3 pathways in non-small-cell lung cancer without any adverse effects in mice, Faseb. J., 36, 10.1096/fj.202200669RR Tomayko, 1989, Determination of subcutaneous tumor size in athymic (nude) mice, Cancer Chemother. Pharmacol., 24, 148, 10.1007/BF00300234 Ianevski, 2022, SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples, Nucleic Acids Res., 50, W739, 10.1093/nar/gkac382 Rawat, 2022, Piperlongumine induces ROS mediated apoptosis by transcriptional regulation of SMAD4/P21/P53 genes and synergizes with doxorubicin in osteosarcoma cells, Chem. Biol. Interact., 354, 10.1016/j.cbi.2022.109832 Yang, 2022, Roles of MET in human cancer, Clin. Chim. Acta, 525, 69, 10.1016/j.cca.2021.12.017 Gibney, 2013, c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma, Ann. Oncol., 24, 343, 10.1093/annonc/mds463 Pisters, 1997, C-met proto-oncogene expression in benign and malignant human renal tissues, J. Urol., 158, 724, 10.1016/S0022-5347(01)64301-5 Tang, 2017, GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses, Nucleic Acids Res., 45, W98, 10.1093/nar/gkx247 Chandrashekar, 2022, UALCAN: an update to the integrated cancer data analysis platform, Neoplasia, 25, 18, 10.1016/j.neo.2022.01.001 Chandrashekar, 2017, UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses, Neoplasia, 19, 649, 10.1016/j.neo.2017.05.002 Markowitz, 2018, Cabozantinib: a multitargeted oral tyrosine kinase inhibitor, Pharmacotherapy, 38, 357, 10.1002/phar.2076 Rauf, 2021, Honokiol: a review of its pharmacological potential and therapeutic insights, Phytomedicine, 90, 10.1016/j.phymed.2021.153647 Ianevski, 2017, SynergyFinder: a web application for analyzing drug combination dose-response matrix data, Bioinformatics, 33, 2413, 10.1093/bioinformatics/btx162 Zhang, 2015, Redox signaling: potential arbitrator of autophagy and apoptosis in therapeutic response, Free Radic. Biol. Med., 89, 452, 10.1016/j.freeradbiomed.2015.08.030 Manda, 2015, The redox biology network in cancer pathophysiology and therapeutics, Redox Biol., 5, 347, 10.1016/j.redox.2015.06.014 Banerjee, 2012, Heme oxygenase-1 promotes survival of renal cancer cells through modulation of apoptosis- and autophagy-regulating molecules, J. Biol. Chem., 287, 32113, 10.1074/jbc.M112.393140 Tang, 2022, OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer, Nucleic Acids Res., 50, D1334, 10.1093/nar/gkab970 Amaravadi, 2007, The roles of therapy-induced autophagy and necrosis in cancer treatment, Clin. Cancer Res., 13, 7271, 10.1158/1078-0432.CCR-07-1595 Recondo, 2020, Targeting MET dysregulation in cancer, Cancer Discov., 10, 922, 10.1158/2159-8290.CD-19-1446 Poillet-Perez, 2015, Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy, Redox Biol., 4, 184, 10.1016/j.redox.2014.12.003 Emdad, 2020, Recent insights into apoptosis and toxic autophagy: the roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic, Semin. Cancer Biol., 66, 140, 10.1016/j.semcancer.2019.07.013 Amaravadi, 2019, Targeting autophagy in cancer: recent advances and future directions, Cancer Discov., 9, 1167, 10.1158/2159-8290.CD-19-0292 Chen, 2010, Autophagy is a therapeutic target in anticancer drug resistance, Biochim. Biophys. Acta Rev. Canc, 1806, 220, 10.1016/j.bbcan.2010.07.003 Liu, 2013, Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells, J. Pharm. Pharmacol., 65, 1622, 10.1111/jphp.12140 Sun, 2011, The RUN domain of Rubicon is important for hVps34 binding, lipid kinase inhibition, and autophagy suppression, J. Biol. Chem., 286, 185, 10.1074/jbc.M110.126425 Liang, 2010, Negative regulation of autophagy, Cell Death Differ., 17, 1807, 10.1038/cdd.2010.115 Kansanen, 2013, The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer, Redox Biol., 1, 45, 10.1016/j.redox.2012.10.001 He, 2020, NRF2, a transcription factor for stress response and beyond, Int. J. Mol. Sci., 21, 4777, 10.3390/ijms21134777 Zimta, 2019, The role of Nrf2 activity in cancer development and progression, Cancers, 11, 1755, 10.3390/cancers11111755 Xue, 2020, Emerging role of NRF2 in ROS-mediated tumor chemoresistance, Biomed. Pharmacother., 131, 10.1016/j.biopha.2020.110676 Komatsu, 2010, The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1, Nat. Cell Biol., 12, 213, 10.1038/ncb2021